Dr. Adam Wolpaw and Dr. Timothy Spear of Children's Hospital of Philadelphia (CHOP) received the Scholar Hope Award and Young Investigator Award respectively from Hyundai Hope On Wheels.

Energy drinks, marketed for boosting energy, concentration, and athletic performance, can pose significant cardiovascular risks, including death. Despite the American Academy of Pediatrics’ advice against caffeine consumption by children and adolescents, the United States remains the least regulated country and should take immediate steps to protect vulnerable populations, leading cardiology researchers at Children’s Hospital of Philadelphia (CHOP) urged in a recent commentary in the Journal of Pediatrics.

Check out our redesigned websites; learn about a new book to help families navigate vaccine decisions; and see updates related to RSV vaccine use in adults.

Dr. Lori Handy recounts a family’s experience with influenza. She also describes the symptoms of influenza and COVID-19 and talks about the importance of getting children vaccinated.

Researchers at Children’s Hospital of Philadelphia (CHOP) demonstrated a promising new approach in the fight against high-risk neuroblastoma, a common and potentially deadly childhood cancer that can occur within the peripheral nervous system. The study, recently published in Nature Communications, found that chimeric antigen receptor (CAR) T-cell therapy targeting two markers on neuroblastoma cancer cells simultaneously boosted overall immune response by engaging adaptive and innate immunity in preclinical models.

Dr. Christopher Cielo, Director of CHOP’s Sleep Center, was featured on Fox29 Philadelphia offering tips on getting children back on a sleep schedule for the new school year.

New findings could guide studies for future therapeutic options for patients

Get information about four aspects of COVID-19 and the vaccine to consider when deciding about getting booster doses.

When it comes to making discoveries in rare diseases, the more patients and researchers involved, the better the chances of finding breakthroughs.

Curing Anthony’s congenital hyperinsulinism was aided by a diagnostic test pioneered at CHOP 20 years ago.